Profiling plasma angiogenesis factors after use of biologics in metastatic colorectal cancer (mCRC): Update results from GI-SCREEN CRC Ukit study.

Yu Sunakawa,Satoshi Yuki,Manabu Shiozawa,Toshiki Masuishi,Tomohiro Nishina,Hisateru Yasui,Takashi Ohta,Naoki Takahashi,Hironaga Satake,Akiyoshi Kanazawa,Masahiro Goto,Hideaki Bando,Hiroya Taniguchi,Yoshinaga Okugawa,Kentaro Yamazaki,Hiromichi Ebi,Yukiko Abe,Shogo Nomura,Chiharu Asano,Takayuki Yoshino

Profiling plasma angiogenesis factors after use of biologics in metastatic colorectal cancer (mCRC): Update results from GI-SCREEN CRC Ukit study.

2021

3529Background: No predictive biomarkers have been validated to determine which patients (pts) with metastatic colorectal cancer (mCRC) benefit the most from angiogenesis inhibitors. Recent studies...

Keywords:

Medicine
Angiogenesis
Internal medicine
Oncology
Colorectal cancer
predictive biomarker

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations